comparemela.com
  1. Home
  2. Live Updates
  3. Harish Shantharam - Breaking News

Latest Breaking News On - Harish shantharam - Page 1 : comparemela.com

CymaBay Therapeutics, Inc (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Third Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

United statesChuck mcwherterLewis stuartGideon hirschfieldYasmeen rahimiRaymond jamesPiper sandlerSteven seedhouseRichard pratleyPaul quinlanHarish shantharamSujal shahAdventhealth research institute in orlandoHarryb helmsley charitableCymabay therapeutics incStudy group

Why Shares of CymaBay Therapeutics Are Soaring Friday

A competitor's drug had a so-so phase 3 trial, lifting the possibilities for CymaBay's lead therapy.

Raymond jamesHarish shantharamSteven seedhouseEd arceHc wainwright coDrug administrationCymabay therapeuticsKaken pharmaceutical

Why CymaBay Therapeutics Stock Nose-Dived This Week

Investors did not warmly greet the latest news from the biotech.

Harish shantharamGilead sciencesCymabay therapeutics

CymaBay Therapeutics, Inc (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Sujal shahKristen kluskaHarish shantharamJay olsonAndy hsiehPatrick dolezalLewis stuartCharles mcwherterRaymond jamesYasmeen rahimiPaul quinlanEd arceMayank mamtaniPiper sandlerSteve seedhouseChuck mcwherter

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.